Pentoxifylline, a Non-Antibiotic Drug, Promotes Adaptation of Clinical Isolates of Staphylococcus aureus via Modulating c-di-AMP Signaling

Published: 7 July 2025| Version 3 | DOI: 10.17632/94bjj7ktmz.3
Contributor:
jinru xie

Description

This dataset contains comprehensive raw data supporting the study on how Staphylococcus aureus adapts under pentoxifylline (PTX) therapy. The data was collected from three S. aureus isolates (L1, L2, L3) obtained from a bacteremia patient receiving PTX combination therapy. The study investigates how non-antibiotic medications can shape bacterial evolution through second messenger modulation, particularly focusing on c-di-AMP signaling pathways.

Files

Categories

Microbiology, Clinical Microbiology

Licence